{"PubmedArticle": [{"MedlineCitation": {"CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "InvestigatorList": [], "OtherID": [], "OtherAbstract": [], "SpaceFlightMission": [], "PMID": "5311483", "DateCompleted": {"Year": "1970", "Month": "10", "Day": "15"}, "DateRevised": {"Year": "2017", "Month": "11", "Day": "16"}, "Article": {"Language": ["hrv"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0374-1338", "JournalIssue": {"Volume": "17", "Issue": "2", "PubDate": {"Year": "1970"}}, "Title": "Reumatizam", "ISOAbbreviation": "Reumatizam"}, "ArticleTitle": "[Positive and negative effects of cytostatic therapy in rheumatic patients].", "Pagination": {"StartPage": "51", "EndPage": "54", "MedlinePgn": "51-4"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Krampac", "ForeName": "I", "Initials": "I"}], "PublicationTypeList": ["Journal Article"], "VernacularTitle": "Pizitivni i negativni efekti citostaticke terapije kod reumatskih bolesnika."}, "MedlineJournalInfo": {"Country": "Croatia", "MedlineTA": "Reumatizam", "NlmUniqueID": "0216650", "ISSNLinking": "0374-1338"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "18D0SL7309", "NameOfSubstance": "Chlorambucil"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}, {"RegistryNumber": "E7WED276I5", "NameOfSubstance": "Mercaptopurine"}, {"RegistryNumber": "F3D5D9P25I", "NameOfSubstance": "Triaziquone"}, {"RegistryNumber": "MRK240IY2L", "NameOfSubstance": "Azathioprine"}, {"RegistryNumber": "YL5FZ2Y5U1", "NameOfSubstance": "Methotrexate"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Azathioprine"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Chlorambucil"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Mercaptopurine"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Methotrexate"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Podophyllum"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Rheumatic Diseases"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Triaziquone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1970", "Month": "1", "Day": "1"}, {"Year": "1970", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1970", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["5311483"]}}], "PubmedBookArticle": []}